🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Just what we feared we would find as the FTC got deeper inside the secret black boxes that are PBMs--huge overcharges for drugs totaling more than $7 billion over six years. It's long past time to pass reforms.dailybreeze.com/2025/01/14/ftc…

Once again, drug companies are telling investors that Medicare price negotiation under the IRA will not hurt their bottom lines, and the future is bright. They tell Congress and the Courts another story, however. endpts.com/drugmakers-aga…

Independent polling consistently shows overwhelming bipartisan support for expanded Medicare negotiation to lower Rx drug prices.

CMS announces 15 more drugs now up for negotiation to lower prices & help make possible lower out-of-pocket expenses for folks on Medicare. The list includes one I take-Pomalyst. Sure hope the Trump Admin uses its bargaining skills to get us a great deal.npr.org/sections/shots…

Love this shot! This is our work--getting patients and their stories before policymakers. And there ain't no higher policymaker than a President. Thanks to Judy for all she does for patients.

Millions of Americans are realizing serious savings on their prescriptions through the new 2022 drug law. We need the Trump administration to continue implementation of Medicare negotiation to help millions more. npr.org/transcripts/nx…

I went up to Capitol Hill yesterday to tell my patient story and emphasize the urgent need to continue implementing the IRA--especially Medicare negotiation. To do otherwise will make drug prices go up, hurting patients and millions of Americans.

Perhaps we'll learn how the Trump Admin plans to keep his promise to reduce drug prices as HHS nominee Robert F. Kennedy, Jr. appears before the Senate Finance Committee at 10am today. finance.senate.gov/hearings/heari…

Good news from CMSGov this AM! Trump Admin will move ahead with Medicare Rx price negotiation! Devil is in the details & how they may tweak the program. Bottom line for us: Do they deliver for patients by lowering prices by at least as much as in 1st round-- average 22%?

We are here in front of Pharma HQ to deliver 202K petitions demanding Pharma and their allies drop the lawsuits and allow Medicare to negotiate. Which is the law! And we will not stop fighting. Patients For Affordable Drugs

RFK, Jr. says: "I met w/PhRMA. I met w/PBMs. My job is to meet w/all the stakeholders." We are patients-no stakeholders are more important. We've been trying to meet with him for almost 2 months. Today I reiterate our request for a meeting on behalf of patients.

Drug companies continue to tell the courts and Congress that the new drug law that lowers prices is crippling them & harming R&D. Yet, so many of them tell investors they are killing it. Novartis reports best earnings in years. endpts.com/novartis-claim…

There are many reasons for early & speedy approval of new cancer drugs in the U.S. One key reason is that the U.S. FDA does a great job. We need to protect & support FDA for patients like me with incurable cancer who need new treatments, and millions of others. h/t Friends of Cancer Research

As President Donald J. Trump meets for at least the 3rd time w/drug company execs, we continue to be disappointed that his administration has not met w/ patients--despite our repeated efforts to engage and offers of support to lower drug prices and help Make America Healthy Again. Below from @Axios

Buyer Beware: The American Action Forum is a subsidiary of the American Action Network which has received-are you sitting down-more than $27 million from pharma since 2010. When you see anything from American Action Forum or American Action Network , remember it's all drug company propaganda bought and paid for.

❌ The ORPHAN Cures Act protects Big Pharma profits at the expense of patients and taxpayers. Congress should reject this loophole and pharma giveaway in order to keep Medicare drug price negotiations strong and put patients before drug company greed.

Important note: The Trump HHS.gov appears to be taking good initial steps to lower Rx prices-implementing the 2022 drug law & especially moving ahead on Medicare negotiation. We applaud them. If this continues as their posture, they have our strong support fiercehealthcare.com/payers/trump-a…

Millions of dollars of secret money from drug companies fund the efforts to undermine Medicare negotiation. The so-callled "pill penalty is a scam/joke. If pharma wants equal time to negotiation for all drugs, let's set it at 9 years. substack.perfectunion.us/p/pharma-lobby…

The Partnership To Fight Chronic Disease-Partnership to Fight Chronic Disease (PFCD)-is a Big PhRMA funded front that doesn't even have support from all the groups it lists on its website. In lobbying reports, PhRMA says the group is a subsidiary. Its Chair-Kenneth Thorpe-was paid $2M 2015-18 rollcall.com/2021/09/30/non…

Industry defenders will argue, “but Revlimid has competition.” Here’s David Mitchell explaining why that’s not actually true.